Schaper Benz & Wise Investment Counsel Inc. WI Has $13.28 Million Holdings in Axon Enterprise, Inc $AXON

Schaper Benz & Wise Investment Counsel Inc. WI increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 6.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 23,682 shares of the biotechnology company’s stock after purchasing an additional 1,360 shares during the quarter. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Axon Enterprise were worth $13,276,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of AXON. Darwin Wealth Management LLC bought a new stake in shares of Axon Enterprise in the 2nd quarter valued at about $37,000. Creative Financial Designs Inc. ADV bought a new position in shares of Axon Enterprise during the fourth quarter worth about $28,000. Camelot Portfolios LLC bought a new position in shares of Axon Enterprise during the fourth quarter worth about $30,000. AlphaCentric Advisors LLC bought a new position in shares of Axon Enterprise during the fourth quarter worth about $34,000. Finally, Strive Financial Group LLC acquired a new position in shares of Axon Enterprise in the fourth quarter worth approximately $41,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Price Performance

Shares of AXON opened at $615.59 on Friday. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $794.29. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. The business’s 50 day moving average price is $523.52 and its two-hundred day moving average price is $473.43. The firm has a market cap of $50.01 billion, a PE ratio of 255.43, a price-to-earnings-growth ratio of 12.24 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company’s quarterly revenue was up 35.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.12 EPS. On average, equities analysts anticipate that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 20,000 shares of the firm’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $10,000,000.00. Following the completion of the sale, the chief executive officer directly owned 3,060,997 shares in the company, valued at approximately $1,530,498,500. This trade represents a 0.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $400.00, for a total transaction of $800,000.00. Following the completion of the sale, the insider directly owned 52,813 shares of the company’s stock, valued at approximately $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 68,989 shares of company stock valued at $36,016,932 over the last 90 days. Insiders own 4.20% of the company’s stock.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Strong Q2 results and raised outlook: Axon exceeded expectations with adjusted earnings of $1.88 per share versus $1.84 expected and revenue of $904.4 million versus $876.4 million expected. Revenue grew 35.3% year over year, and management’s improved outlook supports the long-term growth story. Should You Buy, Hold or Sell AXON Stock Post Q2 Earnings Release?
• Positive Sentiment: Connected Devices momentum: TASER devices, body cameras and counter-drone products are driving strong hardware demand. Continued adoption of these products, combined with Axon’s cloud-based evidence and records software, reinforces the company’s integrated platform strategy. Will Strength in Connected Devices Unit Continue to Drive AXON’s Growth?
• Positive Sentiment: Bullish strategic commentary: Analysts highlighted Axon as a strong contender in law-enforcement technology, while coverage pointed to new artificial-intelligence capabilities as an additional growth catalyst for public-safety customers. Axon: A Strong Contender in Law Enforcement Tech
• Neutral Sentiment: Technical consolidation: AXON remains in a strong broader uptrend but has recently consolidated, leaving investors watching whether momentum resumes or the rally pauses. Stock of the Day: Is the Axon Rally Over?
• Negative Sentiment: Valuation and profitability risks: Despite strong revenue growth, analysts cautioned that Axon’s high earnings multiple, elevated costs, debt and relatively modest margins reduce its near-term appeal. Memory costs and counter-drone investments could also pressure profitability if spending rises faster than sales.
• Negative Sentiment: CEO share sale: CEO Patrick Smith sold 9,930 shares worth approximately $5.45 million. The transaction occurred under a pre-arranged Rule 10b5-1 plan and represented only 0.33% of his holdings, making it a limited signal but a potential source of investor caution.

Analysts Set New Price Targets

A number of research firms have weighed in on AXON. Royal Bank Of Canada reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Barclays boosted their price target on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Morgan Stanley increased their price objective on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Finally, TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $730.92.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.